Literature DB >> 7651724

Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain.

M Machide1, H Mano, K Todokoro.   

Abstract

Although hematopoietic cytokine receptors lack tyrosine kinase domains, the binding of their ligands to the receptors induce rapid tyrosine phosphorylation of various cellular target proteins. The specific tyrosine kinases which phosphorylate these substrates, however, have not been identified, other than that JAK kinases which phosphorylate STAT proteins and the receptors. We found that the c-vav proto-oncogene product, Vav, is rapidly and transiently tyrosine-phosphorylated in response to erythropoietin and IL3 stimulations and that Tec kinase is also transiently activated by these cytokines. Immunoprecipitation experiments demonstrated that Tec kinase binds to Vav upon these cytokine stimulations and that Grb2 constitutively associates with Vav. In vitro binding assays showed that erythropoietin and IL3 stimulation induce the specific binding of Vav to Tec kinase through Tec homology domains. We therefore concluded that Tec kinase is one of the key enzymes in Epo and IL3 receptor-mediated signaling pathways and that Vav plays an important role in the cytokine receptor-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651724

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins.

Authors:  K Nishigaki; C Hanson; T Ohashi; D Thompson; K Muszynski; S Ruscetti
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Regulatory and signaling properties of the Vav family.

Authors:  X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Localization of Tec29 to ring canals is mediated by Src64 and PtdIns(3,4,5)P3-dependent mechanisms.

Authors:  Ning Lu; Douglas J Guarnieri; Michael A Simon
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

4.  Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation.

Authors:  Y T Tsai; Y H Su; S S Fang; T N Huang; Y Qiu; Y S Jou; H M Shih; H J Kung; R H Chen
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Novel recognition mode between Vav and Grb2 SH3 domains.

Authors:  M Nishida; K Nagata; Y Hachimori; M Horiuchi; K Ogura; V Mandiyan; J Schlessinger; F Inagaki
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

6.  Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase.

Authors:  Y Kubota; T Tanaka; A Kitanaka; H Ohnishi; Y Okutani; M Waki; T Ishida; H Kamano
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

7.  Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals.

Authors:  A M Scharenberg; O El-Hillal; D A Fruman; L O Beitz; Z Li; S Lin; I Gout; L C Cantley; D J Rawlings; J P Kinet
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

8.  Molecular cloning of a docking protein, BRDG1, that acts downstream of the Tec tyrosine kinase.

Authors:  K Ohya; S Kajigaya; A Kitanaka; K Yoshida; A Miyazato; Y Yamashita; T Yamanaka; U Ikeda; K Shimada; K Ozawa; H Mano
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

9.  Tec/Bmx non-receptor tyrosine kinases are involved in regulation of Rho and serum response factor by Galpha12/13.

Authors:  J Mao; W Xie; H Yuan; M I Simon; H Mano; D Wu
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

10.  Vav1 transduces T cell receptor signals to the activation of phospholipase C-gamma1 via phosphoinositide 3-kinase-dependent and -independent pathways.

Authors:  Lucinda F Reynolds; Lesley A Smyth; Trisha Norton; Norman Freshney; Julian Downward; Dimitris Kioussis; Victor L J Tybulewicz
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.